Tetrafluoro-m-phenylenediamine dihydrochloride → 2-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)-8-((trans)-3-fluoropiperidin-4-yloxy)quinoline dihydrochloride
反応式
C1(N)C(F)=C(F)C(F)=C(N)C=1F.[ClH:13].Cl.F[C@H]1[C@H](OC2C=CC=C3C=2N=CC=C3)CCNC1.[N:33]1[N:34]=[C:35]([C:42]2[CH:51]=[CH:50][C:49]3[C:44](=[C:45]([O:52][C@@H:53]4[CH2:58][CH2:57][NH:56][CH2:55][C@H:54]4[F:59])[CH:46]=[CH:47][CH:48]=3)[N:43]=2)[N:36]2[CH:41]=[CH:40][CH:39]=[CH:38][C:37]=12>O>[ClH:13].[ClH:13].[N:33]1[N:34]=[C:35]([C:42]2[CH:51]=[CH:50][C:49]3[C:44](=[C:45]([O:52][C@@H:53]4[CH2:58][CH2:57][NH:56][CH2:55][C@H:54]4[F:59])[CH:46]=[CH:47][CH:48]=3)[N:43]=2)[N:36]2[CH:41]=[CH:40][CH:39]=[CH:38][C:37]=12参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
Preparation of the dihydrochloride salt of Enantiomer 2 of 2-k [1,2,4]triazolo[4,3-a]pyridin-3-yl)-8-((trans)-3-fluoropiperidin-4-yloxy)quinoline: Prepared as described in Example 94 using non-racemic 2-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-8-((trans)-3-fluoropiperidin-4-yloxy)quinoline in Step 4C. Specific rotation: [α]20D=+2.7° (c=0.45, 1:1 water/95% ethanol).
後処理
- customPrepared
出典と根拠
- ORDレコード
- ord-992da550797e48229e0b30463ce69240
- 出典データセット
- uspto-grants-2013_11
- 特許番号
- US08575145B2
反応ノート
読み込み中…